Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
700.32
596.52
1,381.66
419.48
377.83
407.64
337.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
700.32
596.52
1,381.66
419.48
377.83
407.64
337.08
Raw Material Cost
91.45
96.99
99.89
80.42
71.57
66.02
70.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.41
16.23
13.62
15.84
14.78
14.45
14.32
Selling and Distribution Expenses
230.33
178.73
261.93
199.24
178.63
161.55
199.38
Other Expenses
26.98
22.16
26.70
21.00
22.46
18.59
18.03
Total Expenditure (Excl Depreciation)
609.03
513.59
642.50
505.47
489.58
427.89
464.58
Operating Profit (PBDIT) excl Other Income
91.30000000000001
82.89999999999999
739.2
-86
-111.7
-20.2
-127.5
Other Income
82.39
54.99
74.10
70.71
77.93
57.08
-30.86
Operating Profit (PBDIT)
201.12
164.20
837.47
11.72
-6.13
60.70
-133.26
Interest
17.41
16.23
13.62
15.84
14.78
14.45
14.32
Exceptional Items
13.76
3.76
-2.15
0.17
2.57
2.74
-1.12
Gross Profit (PBDT)
608.86
499.53
1,281.76
339.06
306.26
341.62
266.49
Depreciation
33.47
32.81
32.56
32.43
31.83
31.54
30.07
Profit Before Tax
164.00
118.91
789.14
-36.38
-50.17
17.44
-178.77
Tax
5.84
2.71
4.15
2.97
3.38
2.05
0.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
161.76
119.41
775.39
-37.51
-51.85
19.21
-178.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
161.76
119.41
775.39
-37.51
-51.85
19.21
-178.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.82
-3.80
10.15
-2.17
-2.22
-3.73
-2.50
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
157.95
115.60
785.54
-39.68
-54.07
15.48
-181.18
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
8,865.58
8,335.04
8,606.24
7,284.98
7,343.50
7,240.93
7,157.15
Earnings per share (EPS)
0.09
0.07
0.44
-0.02
-0.03
0.01
-0.1
Diluted Earnings per share
0.09
0.07
0.44
-0.02
-0.03
0.01
-0.1
Operating Profit Margin (Excl OI)
12.17%
12.81%
52.89%
-21.79%
-30.67%
-6.85%
-39.3%
Gross Profit Margin
28.2%
25.44%
59.47%
-0.94%
-4.85%
12.02%
-44.11%
PAT Margin
23.1%
20.02%
56.12%
-8.94%
-13.72%
4.71%
-53.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 85.36% vs 37.83% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 391.87% vs 59.02% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 241.14% vs 31.85% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 17.57% vs 159.65% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of InnoCare Pharma Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
700.32
0
700.32
Other Operating Income
0.00
0.00
0.00
Total Operating income
700.32
0
700.32
Raw Material Cost
91.45
0
91.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.41
0
17.41
Selling and Distribution Expenses
230.33
0
230.33
Other Expenses
26.98
0.00
26.98
Total Expenditure (Excl Depreciation)
609.03
0
609.03
Operating Profit (PBDIT) excl Other Income
91.28
0.00
91.28
Other Income
82.39
0
82.39
Operating Profit (PBDIT)
201.12
0
201.12
Interest
17.41
0
17.41
Exceptional Items
13.76
0
13.76
Gross Profit (PBDT)
608.86
0
608.86
Depreciation
33.47
0
33.47
Profit Before Tax
164.00
0
164.00
Tax
5.84
0
5.84
Provisions and contingencies
0
0
0.00
Profit After Tax
161.76
0
161.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
161.76
0
161.76
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.82
0
-3.82
Other related items
0.00
0.00
0.00
Consolidated Net Profit
157.95
0
157.95
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
8,865.58
0
8,865.58
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
12.17%
0%
0.00
12.17%
Gross Profit Margin
28.20%
0%
0.00
28.20%
PAT Margin
23.10%
0%
0.00
23.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 70.03 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 17.40% vs -56.83% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 85.36% vs 37.83% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.79 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 36.59% vs -85.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 391.87% vs 59.02% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.87 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.70% vs -85.70% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 241.14% vs 31.85% in Jun 2025
Quarterly - Interest
Interest 1.74 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 7.41% vs 19.12% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.57% vs 159.65% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.17%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
